Lipum AB - interim report for the period July – September 2021
Press release: Umeå, 26 November 2021. Lipum AB (publ) has published the interim report for period July to September 2021. Below is a brief summary, a complete report (only in Swedish) is available on the company's website .CEO Einar Pontén comments: “We are progressing according to plan and both toxicology- and safety studies, according to GLP, as well as GMP manufacturing of SOL-116 were initiated during the period. We have also strengthened our organization in preparation for the clinical stage and Flerie Invest AB, a reputable investment company